Interestingly, selectively replacing SMN in astrocytes alone partially attenuated their pro-inflammatory profile, improved neuromuscular circuitry, and extended the life span of SMA model mice, suggesting that glia may contribute to the SMA disease phenotype [77]. The gene discussed is SMN2; the disease is proximal spinal muscular atrophy.